The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

This publication has 24 references indexed in Scilit:

• Rejection Treatment and Cytomegalovirus Infection as Risk Factors for Pneumocystis carinii Pneumonia in Renal Transplant Recipients
  Clinical Infectious Diseases, 1996
• PROPHYLACTIC GANCICLOVIR TREATMENT REDUCES FUNGAL AS WELL AS CYTOMEGALOVIRUS INFECTIONS AFTER HEART TRANSPLANTATION1,2
  Transplantation, 1995
• Infections in Liver Transplant Recipients
  Clinical Infectious Diseases, 1995
• Antigenemia in the Diagnosis and Monitoring of Active Cytomegalovirus Infection after Liver Transplantation
  The Journal of Infectious Diseases, 1991
• Incidence, Distribution, and Outcome of Episodes of Infection in 100 Orthotopic Liver Transplantations
  Mayo Clinic Proceedings, 1989
• Symptomatic Cytomegalovirus Infection as a Significant Risk Factor for Major Infections After Cardiac Transplantation
  The Journal of Infectious Diseases, 1988
• Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
  New England Journal of Medicine, 1987
• THE EFFECT OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTION ON T LYMPHOCYTE SUBSETS IN CARDIAC TRANSPLANT PATIENTS ON CYCLOSPORINE
  Transplantation, 1984
• Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation
  New England Journal of Medicine, 1983
• Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection
  New England Journal of Medicine, 1978